Authentic Semaglutide Peptide for Sale – Semaglutide Peptide (GLP-1 Receptor Agonist) – High Purity ≥99% | cGMP Grade for Metabolic Research

Semaglutide Peptide is a synthetic 31-amino acid analog of human glucagon-like peptide-1 (GLP-1) engineered for extended duration and enhanced potency. It is one of the most extensively studied GLP-1 receptor agonists in metabolic research.

Semaglutide incorporates key structural modifications: substitution of Lysine at position 20 with a non-proteinogenic amino acid (Aib) for DPP-IV resistance, and a C18 fatty diacid conjugation at Lysine 26 for albumin binding. These modifications provide a research half-life of approximately 7 days, enabling once-weekly dosing models.

Looking for Semaglutide peptide for sale from a trusted supplier? Shanghai AmbioPharm, Inc. provides high purity Semaglutide peptide manufactured under advanced, quality-controlled environments to support modern research applications. Semaglutide is widely studied in metabolic and peptide research, making it a highly sought-after compound in scientific and biotech laboratories.

Our Semaglutide peptide is synthesized using pharmaceutical-grade processes to ensure ≥99% purity, excellent stability, and consistent batch performance. Each order includes a Certificate of Analysis (COA), providing full transparency and verification of product quality. With our manufacturing facility in Shanghai and USA-based distribution support, we ensure fast, secure shipping and dependable supply for both small-scale and bulk orders.

As a selective GLP-1 receptor agonist, Semaglutide enhances glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite via central nervous system pathways. Its distinct mechanism addresses both glycemic control and caloric intake.

At Shanghai AmbioPharm, Inc., we supply high-purity Semaglutide Peptide (≥99% by HPLC) for advanced metabolic research. Our cGMP-grade material is synthesized in our FDA-inspected Shanghai facility and available for fast U.S. delivery from our Clearwater, South Carolina warehouse.

Key Product Details:

• Sequence: 31-amino acid GLP-1 analog with Aib substitutions and C18 fatty diacid

• CAS Number: 910463-68-2 (Semaglutide base)

• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉

• Molecular Weight: 4,113.6 g/mol

• Purity: ≥99% (HPLC)

• Form: Lyophilized white powder

• Storage: -20°C, protected from light, desiccated

• Grade Available: Non-GMP (R&D) and cGMP (clinical preparatory)

• Amino Acids: 31-mer

• Key Modifications: Aib substitutions (DPP-IV resistance), C18 fatty diacid (albumin binding)

• Research Half-Life: Approximately 7 days (once-weekly profile)

• Receptor Target: GLP-1R (selective)

Why Choose AmbioPharm for Semaglutide Peptide?

As a global peptide CDMO, AmbioPharm combines scientific expertise with large-scale manufacturing capabilities. Choosing our Semaglutide peptide for sale ensures premium quality, trusted sourcing, and reliable delivery tailored to your research needs.

• ✅ FDA-inspected cGMP manufacturing

• ✅ Full Certificate of Analysis (COA) with each batch

• ✅ HPLC chromatogram and mass spec data included

• ✅ Verified fatty acid conjugation confirmation

• ✅ Low endotoxin levels (<1 EU/mg)

• ✅ U.S. warehousing – fast domestic shipping from South Carolina

• ✅ Batch-to-batch consistency for longitudinal metabolic studies

Research Applications:

• GLP-1 receptor pharmacology and signaling studies

• Glucose-dependent insulin secretion research

• Appetite regulation and satiety mechanism studies

• Gastric emptying and gastrointestinal motility research

• Beta-cell preservation and function models

• Obesity and weight management research

• Type 2 diabetes metabolic research

• Cardiovascular and NAFLD research

Mechanism of Action:
Semaglutide selectively activates GLP-1 receptors on pancreatic beta cells, enhancing glucose-dependent insulin secretion. It also suppresses glucagon release from alpha cells, delays gastric emptying, and activates GLP-1 receptors in the hypothalamus to reduce appetite. The C18 fatty diacid enables reversible albumin binding, extending half-life while maintaining receptor engagement. Aib substitutions prevent DPP-IV degradation.

 Intended Use: For laboratory research purposes only. Not for human consumption or clinical use without regulatory approval.

Ordering Information:

• Minimum Order Quantity (MOQ): 10mg (R&D), 10g+ (cGMP bulk)

• Lead Time: 2-3 weeks (non-GMP), 6-8 weeks (cGMP)

• Shipping: From Clearwater, SC, USA (2-5 days domestic)